Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 569752

Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis


Vujasinović, Ines; Paravić-Radičević, Andrea; Mlinarić-Majerski, Kata; Brajša, Karmen; Bertoša, Branimir
Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis // Bioorganic & medicinal chemistry, 20 (2012), 6; 2101-2110 doi:10.1016/j.bmc.2012.01.032 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 569752 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis

Autori
Vujasinović, Ines ; Paravić-Radičević, Andrea ; Mlinarić-Majerski, Kata ; Brajša, Karmen ; Bertoša, Branimir

Izvornik
Bioorganic & medicinal chemistry (0968-0896) 20 (2012), 6; 2101-2110

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
QSAR ; VolSurf+ ; pyrazole ; amidooxime ; antitumor activity ; A549 and NCIH23 lung cancer cells

Sažetak
Using literature data on anticancer activity of pyrazole derivatives, 3D-QSAR models were developed and 3D-QSAR analysis was performed. The 3D-QSAR analysis enabled identification of molecular properties that have the highest impact on antitumor activity against lung cancer cells. The results of 3D-QSAR analysis were taken into account while new compounds were designed. Obtained 3D-QSAR models were used for prediction of activity of new compounds. In this way, design of new compounds was guided by 3D-QSAR analysis which was performed on literature data. Ten new pyrazole derivatives were synthesised and their antitumor activities against A549 and NCIH23 lung cancer cells were validated. In order to obtain full profile of anticancer activity, cells viability (MTS) assays were combined with cell proliferation (BrdU) assays which measure actively dividing cells in treated sample. Experimental measurements showed good agreement between predicted and measured activities for majority of compounds. Also, anticancer activities of new pyrazole derivatives pointed to the chemical groups that can be useful in designing antitumor molecules. Substitution of hydrazine linker with rigid, 1, 2, 4-oxadiazole moiety resulted in compound 10, which has low (if any) cytotoxic activity and high potential cytostatic activity. Therefore, compound 10 presents a good starting point for design of new, more potent and safer anticancer therapeutics.

Izvorni jezik
Engleski

Znanstvena područja
Fizika, Kemija, Biologija



POVEZANOST RADA


Projekti:
098-0982933-2911 - Kavezasti spojevi: ugradbene jedinice u molekularnim sustavima (Majerski, Kata, MZOS ) ( CroRIS)
098-1191344-2860 - Proučavanje biomakromolekula računalnim metodama i razvoj novih algoritama (Tomić, Sanja, MZOS ) ( CroRIS)

Ustanove:
Pliva-Istraživački institut,
Institut "Ruđer Bošković", Zagreb

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com dx.doi.org

Citiraj ovu publikaciju:

Vujasinović, Ines; Paravić-Radičević, Andrea; Mlinarić-Majerski, Kata; Brajša, Karmen; Bertoša, Branimir
Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis // Bioorganic & medicinal chemistry, 20 (2012), 6; 2101-2110 doi:10.1016/j.bmc.2012.01.032 (međunarodna recenzija, članak, znanstveni)
Vujasinović, I., Paravić-Radičević, A., Mlinarić-Majerski, K., Brajša, K. & Bertoša, B. (2012) Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis. Bioorganic & medicinal chemistry, 20 (6), 2101-2110 doi:10.1016/j.bmc.2012.01.032.
@article{article, author = {Vujasinovi\'{c}, Ines and Paravi\'{c}-Radi\v{c}evi\'{c}, Andrea and Mlinari\'{c}-Majerski, Kata and Braj\v{s}a, Karmen and Berto\v{s}a, Branimir}, year = {2012}, pages = {2101-2110}, DOI = {10.1016/j.bmc.2012.01.032}, keywords = {QSAR, VolSurf+, pyrazole, amidooxime, antitumor activity, A549 and NCIH23 lung cancer cells}, journal = {Bioorganic and medicinal chemistry}, doi = {10.1016/j.bmc.2012.01.032}, volume = {20}, number = {6}, issn = {0968-0896}, title = {Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis}, keyword = {QSAR, VolSurf+, pyrazole, amidooxime, antitumor activity, A549 and NCIH23 lung cancer cells} }
@article{article, author = {Vujasinovi\'{c}, Ines and Paravi\'{c}-Radi\v{c}evi\'{c}, Andrea and Mlinari\'{c}-Majerski, Kata and Braj\v{s}a, Karmen and Berto\v{s}a, Branimir}, year = {2012}, pages = {2101-2110}, DOI = {10.1016/j.bmc.2012.01.032}, keywords = {QSAR, VolSurf+, pyrazole, amidooxime, antitumor activity, A549 and NCIH23 lung cancer cells}, journal = {Bioorganic and medicinal chemistry}, doi = {10.1016/j.bmc.2012.01.032}, volume = {20}, number = {6}, issn = {0968-0896}, title = {Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis}, keyword = {QSAR, VolSurf+, pyrazole, amidooxime, antitumor activity, A549 and NCIH23 lung cancer cells} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font